Azamian Bobak R. sold TARS
August 11, 2025 · Form 4 insider transaction
Azamian Bobak R. sold 6,000 shares of Tarsus Pharmaceuticals, Inc. at $50.00 per share, a transaction worth $300.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,000
Price
$50.00
Total value
$300.0K
InsiderAzamian Bobak R.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after818,106
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.; The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.